AMSBIO introduces range of cytosections for antibody screening, immunohistochemistry protocol development
AMSBIO has launched a comprehensive range of cytosections that offer a verified, reproducible and renewable source of positive / negative controls where the expression of the target biomarker is confirmed for accuracy and specificity by an immunoassay.
